siRNA 화학물질, 링커 및 시약 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global siRNA chemical linkers and reagents market size is expected to reach USD 3149.74 Million in 2034 from USD 951.91 Million in 2025, growing at a CAGR of 14.22 during 2026-2034.This market is witnessing rapid growth as small interfering RNA technologies continue gaining importance in gene silencing research, precision medicine, and advanced therapeutic development. Chemicals, linkers, and reagents used in siRNA synthesis play a critical role in improving molecular stability, delivery efficiency, target specificity, and therapeutic performance. Rising investments in biotechnology, genomics, and pharmaceutical research are significantly accelerating market expansion worldwide.

Growing clinical development of RNA-based therapeutics, increasing research into genetic disorders, cancer treatments, infectious diseases, and rare diseases are driving demand for high-quality siRNA manufacturing materials. Continuous innovation in conjugation chemistry, nucleotide modification, lipid delivery systems, and synthesis technologies is enhancing product performance while improving commercial scalability. Expanding collaborations between pharmaceutical companies, biotechnology firms, and research institutions are further supporting industry growth.

The market is expected to maintain exceptional growth as RNA therapeutics, personalized medicine, and gene-editing technologies continue advancing globally. Continuous improvements in chemical synthesis, delivery platforms, automated manufacturing, and regulatory compliance will strengthen commercial adoption. Increasing investments in precision healthcare, expanding clinical trials, and growing commercialization of RNA-based medicines will continue creating substantial long-term market opportunities.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

• siRNA Synthesis Chemicals
• Chemical Modifiers
• Linkers
• Conjugation Reagents
• Delivery-Related Reagents
• Others

By Application

• Therapeutics Development
• Research & Discovery
• Drug Delivery Platform Development
• Others

By End-use

• Pharmaceutical & Biotechnology Companies
• CMOs / CDMOs
• Academic & Research Institutes
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Danaher Corporation, Bachem, LGC Biosearch Technologies, WuXi AppTec, Nitto Denko Avecia, Bio-Synthesis, Maravai LifeSciences, Glen Research, ChemGenes Corporation, Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals, Silence Therapeutics, Ionis Pharmaceuticals, Arbutus Biopharma, Benitec Biopharma, Marina Biotech, Quark Pharmaceuticals, RXi Pharmaceuticals, Sirnaomics, Genevant Sciences, BioNTech, Moderna, Pfizer Inc., Sanofi S.A., Roche Holding AG, Merck and Co.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SIRNA CHEMICAL, LINKERS AND REAGENTS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. siRNA Synthesis Chemicals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Chemical Modifiers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Linkers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Conjugation Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Delivery-Related Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SIRNA CHEMICAL, LINKERS AND REAGENTS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Therapeutics Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Research & Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Drug Delivery Platform Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SIRNA CHEMICAL, LINKERS AND REAGENTS MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. CMOs / CDMOs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SIRNA CHEMICAL, LINKERS AND REAGENTS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SIRNA CHEMICAL, LINKERS AND REAGENTS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific
  • 9.2.2 Merck KGaA
  • 9.2.3 Agilent Technologies
  • 9.2.4 Danaher Corporation
  • 9.2.5 Bachem
  • 9.2.6 LGC Biosearch Technologies
  • 9.2.7 WuXi AppTec
  • 9.2.8 Nitto Denko Avecia
  • 9.2.9 Bio-Synthesis
  • 9.2.10 Maravai LifeSciences
  • 9.2.11 Glen Research
  • 9.2.12 ChemGenes Corporation
  • 9.2.13 Alnylam Pharmaceuticals
  • 9.2.14 Arrowhead Pharmaceuticals
  • 9.2.15 Silence Therapeutics
  • 9.2.16 Ionis Pharmaceuticals
  • 9.2.17 Arbutus Biopharma
  • 9.2.18 Benitec Biopharma
  • 9.2.19 Marina Biotech
  • 9.2.20 Quark Pharmaceuticals
  • 9.2.21 RXi Pharmaceuticals
  • 9.2.22 Sirnaomics
  • 9.2.23 Genevant Sciences
  • 9.2.24 BioNTech
  • 9.2.25 Moderna
  • 9.2.26 Pfizer Inc
  • 9.2.27 Sanofi S.A
  • 9.2.28 Roche Holding AG
  • 9.2.29 Merck And Co